BCAL DIAGNOSTICS LIMITED ANNUAL

Directors' Report

DIRECTORS’ REPORT Your directors present their report together with the financial statements on BCAL Diagnostics Limited (the Company) and its controlled entities (BCAL Diagnostics or the “Group”) for the year ended 30 June 2026. DIRECTORS The following persons were directors of BCAL Diagnostics Limited during the financial year or as at the date of this report: Jayne Shaw Non-Executive Chair Jonathan Trollip Non-Executive Director David Darling Non-Executive Director John Hurrell Non-Executive Director Mark McConnell Non-Executive Director, appointed 1 February 2026 Ronald Phillips Non-Executive Director, resigned 28 August 2025 Mark Burrows Non-Executive Director, resigned 28 August 2025 INFORMATION ON DIRECTORS AS AT REPORT DATE Jayne Shaw trained as a Registered Nurse in the UK, on arrival in Australia Jayne became a Director of Nursing and Chief Executive Officer of two private hospitals. Following this, Ms Shaw established an Australian and international consulting business which was sold to Healthsouth a large US Healthcare company. Ms Shaw then became the Co-founder of Vision Group, an Ophthalmic Doctor equity consolidation model that was successfully listed on the ASX. Ms Shaw has been a member of a number of private healthcare boards involved with Jayne Shaw specialist consolidation including cardiology, orthopaedics, and women’s health, Non-Executive Chair and continued to work with private equity firms on local and International Healthcare transactions. Appointed as a Director on 15 February 2010 Ms Shaw, together with Mr Ronald Phillips, was a co-owner of Sydney Breast Clinic and a co-founder of BCAL Diagnostics. Current listed company Board position - PharmX Technologies Ltd (ASX: PHX) since 15 October 2020. Shares held as at date of this report: 35,803,888 Share options held as at date of this report: 2,000,000 7 BCAL DIAGNOSTICS LIMITED | ASX: BDX ylno esu lanosrep roF Mr Trollip is a globally experienced professional non-executive Director with over 30 years of commercial, corporate, governance and legal and transactional expertise. Mr Trollip is currently non-executive Chairman of ASX listed Staude Global Value Fund Limited, Plato Income Maximiser Limited, Spheria Emerging Companies Limited and a non-executive director of ASX and LSE listed Kore Potash PLC. Mr Trollip was previously chairman of ASX listed Future Generation Australia Limited